InfuSystem (INFU)
Supplies and manages infusion and wound-care equipment for clinics, patients, and care providers.
$12.16
At close+0.06 (+0.50%)
In millions of USD, except per-share figures
| In millions | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 32 | 32 | 34 | 35 | 34 | 35 | 36 | 36 | 36 | 34 | 37 |
| Cost of revenue | 16 | 16 | 17 | 16 | 16 | 16 | 16 | 16 | 16 | 14 | 16 |
| Gross profit | 16 | 16 | 17 | 19 | 18 | 19 | 20 | 21 | 20 | 20 | 21 |
| 14 | 17 | 15 | 16 | 16 | 19 | 16 | 17 | 17 | 18 | 17 | |
| 13 | 17 | 15 | 16 | 15 | 18 | 16 | 17 | 17 | 18 | 17 | |
| Selling & marketing | 4 | 3 | 3 | 3 | 2 | 3 | 3 | 2 | 2 | 3 | 3 |
| General & administrative | 10 | 14 | 12 | 13 | 13 | 15 | 13 | 14 | 14 | 15 | 14 |
| Other expenses | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income | 1 | −1 | 2 | 3 | 3 | 1 | 4 | 4 | 4 | 2 | 4 |
| −1 | 0 | −1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Interest expense | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | 1 | −1 | 1 | 3 | 2 | 0 | 3 | 3 | 3 | 1 | 4 |
| Income tax expense | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 |
| Net income from continuing operations | 0 | −1 | 1 | 2 | 1 | 0 | 3 | 2 | 2 | 1 | 3 |
| Net income | 0 | −1 | 1 | 2 | 1 | 0 | 3 | 2 | 2 | 1 | 3 |
| EPS, basic | $0.00 | −$0.05 | $0.03 | $0.08 | $0.04 | −$0.01 | $0.12 | $0.11 | $0.10 | $0.05 | $0.16 |
| EPS, diluted | $0.00 | −$0.05 | $0.03 | $0.08 | $0.04 | −$0.01 | $0.12 | $0.11 | $0.10 | $0.05 | $0.15 |
| Weighted average shares, basic | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 20 | 20 | 20 |
| Weighted average shares, diluted | 22 | 21 | 22 | 22 | 22 | 21 | 21 | 21 | 21 | 21 | 21 |
| EBITDA | 4 | 2 | 5 | 6 | 6 | 4 | 7 | 7 | 7 | 4 | 4 |
| Depreciation & amortization | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 0 |
| EBIT | 1 | −1 | 2 | 3 | 3 | 1 | 4 | 4 | 4 | 1 | 4 |